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 Planaria: an animal model that integrates development, 
regeneration and pharmacology
ONÉ R. PAGÁN*
Department of Biology, West Chester University, West Chester, PA, USA
ABSTRACT  Although planarians are established model organisms in developmental biology and 
regeneration studies, in the last forty years or so, they have caught the attention of pharmacolo-
gists, especially to study the pharmacology of drugs of abuse. This review covers the following 
topics: some fundamentals of the history of animal models and planarians in biomedical research; 
an abbreviated story of systematic pharmacology research using planarians as a model organism; 
an example of how planarians are contributing to the search for compounds against acute cocaine 
toxicity; an analysis of the number of papers on planarians and pharmacological topics from 1900-
2016; some perspectives on pharmacology in developmental and regeneration studies, arguing 
in favor of the planarian model as a leading subject for this interdisciplinary area of research, and 
finally some concluding thoughts.
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Introduction
The study of model organisms for the purpose of uncovering 
fundamental biological principles is a leading source of multiple 
applications relevant to the medical sciences. When the original 
natural philosophers studied nature for pure knowledge’s sake, 
they mainly followed Aristotle’s maxim: “Philosophy starts in won-
der and wonderment” (Aristotle, 384 BC). In time, not long after 
the medical sciences diverged from pure natural history, their true 
development was based on experimental science and the use of 
model organisms to better further our grasp of normal physiological 
mechanisms in humans, a tradition that continues to this day. As a 
consequence of this tradition, studies based on model organisms 
allow us to learn about the diseases that arise upon disruption of 
normal human physiology.
Most scholars agree that the beginnings of animal experimenta-
tion for the explicit purpose of advancing the biomedical sciences 
began in the 1800s with the French scientist Claude Bernard, the 
father of experimental physiology (Barker Jørgensen, 2001). Later 
on, in the early 20th century the Danish experimental physiologist 
and Nobelist August Krogh independently articulated Bernard’s 
insights when he stated:
“For a large number of [biological] problems there will be some 
animal of choice, or a few such animals, on which it can be most 
conveniently studied” (Krogh, 1929).
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This statement lies at the heart of modern biomedical research, 
and was eventually formalized as “The Krogh Principle”. This 
formalization was an idea of another Nobelist, Hans Krebs of the 
Tricarboxylic Acid Cycle fame—among several other important 
biochemical discoveries—(Krebs, 1975). Biologists have applied 
Krogh’s Principle to virtually every aspect of the life sciences, but 
most importantly for the purposes of this review, to developmental 
and regeneration biology (Barker Jørgensen, 2001; Lindstedt, 
2014). The contributions of virtually every model organism to ex-
perimental biology are exemplary illustrations of Krogh’s Principle 
in action. Nevertheless, it is important not to lose sight of the fact 
that no particular organism is useful for every research problem. 
Also, not all aspects of the normal physiology of model organisms 
represent an ideal surrogate for human biology. These apparent 
deviations from Krogh’s Principle were articulated by refining the 
principle through the following corollary:
“No single organism (or technique) exists that can provide easy 
access to the diversity of hidden mechanisms that underlie all in-
teresting and important physiological and biochemical problems” 
(Wayne and Staves, 1996).
Although Krogh expressed his views on animal models in light 
of his own area of expertise (comparative physiology) and emphati-
cally argued in favor of the practical applications of research, he, 
as Aristotle before him, possessed a keen aesthetic appreciation 
for the joy of pure biological knowledge. In Krogh’s words:
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“You will find in the lower animals mechanisms and adaptations 
of exquisite beauty and the most surprising character…” (Krogh, 
1929). 
I could not agree more with Krogh’s appreciation of “lower 
animals”, as I happen to work with one, a type of living being that 
exemplifies Krogh’s practical yet lyrical description with distinction. 
This organism is the planarian.
Planarians
Although “planaria” and its derivations (planarian, planarians) 
are widely used to describe a specific type of common invertebrate, 
there is a minor controversy among specialists about using these 
terms in a formal scientific setting. Through informal conversations 
with colleagues, as well as by examining the scientific literature, it 
is evident that “planaria” is a rather nonspecific way of naming the 
organisms of interest. In essence, planarian merely means “flat-
worm”, which by itself usually refers to a wide variety of organisms 
which may or may not be closely related phylogenetically (Egger 
et al., 2009). In fact, experts in the field have argued in favor of 
permanently discontinuing the use of “planaria” in the scientific 
literature (Egger et al., 2007). Only time will tell if this idea gains 
traction. Nonetheless, in this review, I will use “planaria” and related 
terms as traditionally used. In order to help in this discussion, I will 
define and describe what they are in the next paragraphs.
Planarians are essentially a series of several species of free-living 
flatworms that display bilateral symmetry. For the purposes of this 
review the planarians most commonly used for scientific research 
belong to the phylum Platyhelminthes, whose most famous and 
highly successful members include a variety of obligate parasites 
that are beyond of the scope of this review (Collins, 2017). The 
best known examples of the free-living Platyhelminthes belong to 
the order Tricladida, a classification criterion based on specific as-
pects of their digestive system morphology (Rohde, 2000). Triclads 
are traditionally further classified based on an ecological context, 
namely whether they live in freshwater, marine, or terrestrial en-
vironments. This ecological classification scheme of triclads is not 
universally accepted and is under revision using molecular biology 
approaches (Alvarez-Presas et al., 2008; Riutort et al., 2012). Most 
of the planarian species used as research animals are freshwater 
species. The most common genera used in research are Girardia, 
Dugesia; (Fig. 1), Schmidtea, Phagocata, and Polycelis (Elliott 
and Sánchez Alvarado, 2013, Newmark and Sánchez Alvarado, 
2002; Saló and Baguñà, 2002; Tessmar-Raible and Arendt, 2003). 
Girardia and Dugesia are the best-known genera with about 75 
identified species so far (Riutort et al., 2012).
Historically, it seems that the earliest printed reference of the 
term “planaria” came from the Danish naturalist Othone Friderico 
Müller in a 1776 book titled “Zoologiae Danicae Prodromus” (Fig. 
2). It is to be noted that many of the flatworm species that Müller 
called “planarians” are currently placed into other taxa of the class 
turbellaria or the phylum rhynchocoela (Alvarez-Presas et al., 2008; 
Riutort et al., 2012).
Although it is undisputable that Müller deserves priority recogni-
tion for the use of the term “planaria”, two years before Müller’s 
book, in 1774, the German naturalist Peter Simon Pallas published 
his book Spicilegia Zoologica, where he showed drawings of sev-
eral worms which for all intent and purposes look like planarians. 
However, he listed these worms as Fasciola, a name that now is 
reserved for a genus of parasitic flatworms (Fig. 3). His drawings 
were so precise and detailed that modern specialists are able to 
identify the depicted planarian species with a high level of certainty.
In the best tradition of the scientific “Age of Wonder” of the 1700s-
1800s, planarians were enthusiastically studied by the naturalists of 
the time, including Charles Darwin (Elliott and Sánchez Alvarado, 
2013; Rieger, 1998; http://darwin-online.org.uk/). Even the father 
of modern genetics, Thomas Hunt Morgan, studied planarians. 
Between 1898 and 1905, Morgan published a series of papers 
and books on the general topic of regeneration, with planarians as 
one of the main research subjects (Sturtevant, 1959). According 
to Morgan himself, planarians came to his attention by reading a 
paper by Dr. Harriet Randolph, of Bryn Mawr College (Randolph, 
1897). Randolph and Morgan collaborated in subsequent works. 
In great part as a consequence of this collaboration, Morgan even 
seriously considered planarians as his choice of model organism 
to study the cellular basis of genetics before favoring the fruit fly, 
Drosophila melanogaster (Adell et al., 2010; Gentile et al., 2011; 
Newmark and Sánchez Alvarado, 1999; Pagán, 2014, chapter 7). 
There is little doubt that if planarians had been Morgan’s choice, 
Fig. 1. Planarian specimen (Girardia sp.) over a 1-cm gridline. Picture 
credit: Pagán Laboratory.
Fig. 2. Cover of Müller’s Prodromus (left) and the page where “planaria” 
appeared for the first time (right). Please note that at the time, planar-
ians were classified as mollusks. Photograph courtesy of Dr. Masaharu 
Kawakatsu, used with permission.
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the history of 20th century genetics could have featured a different 
protagonist!
The history of planarians in biology is quite curious to say the 
least. There were two specific time periods in which despite an 
initial interest in the worms, researchers stopped using them as 
animal models in favor of other organisms, for a variety of rea-
sons. Some authors have speculated on the specific reasons for 
this apparent decline of scientific interest. The first of such time 
periods was around Morgan’s time, in a series of well-documented 
episodes described and analyzed in detail in a work appropriately 
titled: “Whatever happened to planaria?” (Mitman and Fausto-
Sterling, 1992).
The reason for the second time period of low popularity of 
planarians (roughly the 1950s-1960s) is not entirely clear and is 
therefore more debated, but this seemed to be related to the (at 
the time controversial) research by James McConnell on memory 
transfer experiments using planarians (Rilling, 1996). McConnell 
also worked, albeit somewhat less controversially, on memory 
retention in trained planarians upon decapitation and brain re-
generation (reviewed in Corning and Ratner, 1967; Pagán, 2014; 
Rilling, 1966). Incidentally, McConnell’s memory retention work 
has recently been replicated using computerized procedures and 
properly designed controls, which renders the concept valid beyond 
any scientific doubt (Blackiston et al., 2015; Neuhof et al., 2016; 
Shomrat and Levin, 2013). Memory research using planarians is 
undoubtedly experiencing an exciting resurgence, but this topic 
is beyond the scope of this review.
Planarians are uniquely situated to contribute to several scientific 
disciplines, including neurobiology. In evolutionary terms, they are 
some of the simplest examples of organisms displaying bilateral 
symmetry and cephalization, including a primitive “brain”, with 
many features similar to vertebrate nervous systems (Sarnat and 
Netsky, 1985, 2002). Depending on the actual definition of what a 
“brain” is (for example see Netsky, 1986) it is generally believed 
that planarians represent the first type of organism possessing 
an actual brain (Agata et al., 1998; Cebrià, 2007; Pagán, 2014; 
Sarnat and Netsky, 1985, 2002; Okamoto et al., 2005; Umesono 
et al., 2011). In addition to the general features of the planarian 
nervous system that are similar to the nervous systems of more 
“advanced” organisms, planarian neurons display closer similarities 
to vertebrate neurons than to invertebrate neurons like insects, for 
example, in terms of cell morphology and physiology (Sarnat and 
Netsky, 1985, 2002). Structurally, the planarian central nervous 
system consists of an anterior brain (sometimes referred to as 
cephalic ganglia) and two longitudinal nerve cords, connected to 
each other with nerve fibers arranged in a ladder-like structure 
(Cebrià, 2007; Lentz, 1968; Okamoto et al., 2005; Fig. 4). Interest-
ingly, most major neurotransmitter systems found in vertebrates are 
also found in the planarian nervous system, which further argues 
in favor of using this animal model in neurobiological investigations 
(Buttarelli et al., 2008; Carolei et al., 1975; Ribeiro et al., 2005).
Additionally, planarians display a surprising variety of behavioral 
responses induced by a wide range of compounds (for descriptions 
of some of such behaviors please see Akiyama et al., 2015; Inoue 
et al., 2015; Cochet-Escartin et al., 2015; Paskin et al., 2014; Raffa 
et al., 2001; Raffa and Desai, 2005; Rawls et al., 2011; Talbot and 
Schötz, 2011; Tallarida et al., 2014). These characteristics makes 
planarians exceptional animal models in neurobiology, but their 
usefulness does not stop there. Their varied and relatively complex 
behavioral responses and the parallels between the anatomy and 
physiology of the vertebrate and the planarian nervous systems 
resulted in the development of planarians as a popular animal 
model in pharmacology and its sister science, toxicology (Alonso 
and Camargo, 2015; Best and Morita 1991; Li, 2016; Pagán et 
al., 2009; Schaeffer, 1993; Stevens et al., 2015). In this review, 
I emphasize the usefulness of planarians in pharmacological 
studies, particularly in terms of neurobiology & behavior. For two 
excellent reviews on planarian toxicology please see Hagstrom 
et al.,2015, 2016).
The beginnings of systematic planarian pharmacology 
research
When considering the fact that planarians share many biologi-
cal features with “higher” organisms, together with their interesting 
drug-induced behaviors, as well as their ease of use, it is no surprise 
that planarians found their way into systematic pharmacological 
research. In retrospect, it is rather surprising that it took so long. 
It is important to point out that most of the pre-1970 planarian 
research was not conducted with the explicit purpose of study-
ing pharmacology, even though many compounds were tested in 
Fig. 3. Cover of Pallas’ Spicilea Zoologica (left) and the page showing 
some worms which are very much like planarians (right). Photograph 
courtesy of Dr. Masaharu Kawakatsu, used with permission.
Fig. 4. A general representation of the planarian 
nervous system. Courtesy of Mr. Alexis G. Pagán.
this invertebrate. Rather, the main objective was 
to use particular compounds in order to exploit 
their specific pharmacological properties, by 
slowing down or even paralyzing the worms to 
facilitate the study of their anatomical or physi-
ological characteristics. In fact, up to the 1970s, 
there were quite a few publications describing 
the effects of a variety of compounds and drugs 
on planarians. More recently, the main emphasis 
on the use of planarians in the pharmacological 
sciences are the specific fields of behavioral- and 
neuro-pharmacology (Buttarelli et al., 2008; Raffa 
and Rawls, 2008). In the late 1960s-early 1970s 
scientists began to realize that planarians showed 
relatively complex behaviors when exposed to 
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substances that induced psychoactive effects in “higher” organisms, 
including vertebrates. Most interestingly, these worms displayed 
various types of behavioral responses when exposed to drugs like 
nicotine and cocaine. These planarian behaviors were evocative of 
behaviors displayed by humans upon abused drug use, particularly 
withdrawal-like behaviors related to physical dependence. These 
facts caught the attention of clinical scientists, who reasoned that 
planarians could be useful as models for the pharmacology of drug 
abuse and other neurological diseases. In this light, the very first 
report on the effects of a drug of abuse in planarians (morphine; 
Needleman, 1967), was reported by a physician, Dr. Herbert 
Needleman of Temple University, the pediatrician/psychiatrist who 
is best known for his groundbreaking work on the neurotoxicity of 
lead exposure and its effects on public health. 
An ocean away in Rome, Italy, Drs. Antonio Carolei, Vito Margotta, 
and Guido Palladini, neurologists at the University La Sapienza, 
Rome, pioneered the systematic use of planarians in pharmacology 
with the publication of their 1975 paper: “Proposal of a New Model 
with Dopaminergic-Cholinergic Interactions for Neuropharmaco-
logical Investigations” (Carolei et al., 1975), coincidentally, the 
same year when Krogh’s Principle was formalized (Krebs, 1975). 
Once again, the remarkable regenerative properties of planar-
ians were behind the interest of biomedical scientists, leading to 
the use of these organisms as animal models. According to Dr. 
Carolei (personal communication), in the 1970s he had a scientific 
conversation with Dr. Palladini, that touched upon the topic of 
immortality. Dr. Palladini observed that planarians were part of a 
select group of animals that showed the potential for immortality due 
to their unusual regeneration capabilities. This comment sparked 
Dr. Carolei’s interest in planarian biology. Their formal scientific 
rationale to study planarians was the analogous neural networks of 
the motor system of planarians with the extrapyramidal system of 
vertebrates, particularly their cholinergic/dopaminergic interactions. 
The extrapyramidal system is a series of neuronal structures that 
control multiple aspects of motor responses in vertebrates. The 
dysfunction of this system leads to a variety of movement disorders 
in humans, with Parkinson’s Disease as probably the best-know 
example (reviewed in Dorman, 2015). In a short time, Drs. Caro-
lei, Margotta, and Palladini, along with several other colleagues, 
began to explore planarians as animal models for neurological 
diseases with a neuropharmacological emphasis, and published 
close to forty papers or book chapters between 1975 and 2008 
on the pharmacology and neurobiology of the planarian Dugesia 
gonocephala, also known as Dugesia japonica (reviewed in But-
tarelli et al., 2008 and in Carolei et al., 2008a,b). Their planarian-
related publications dealt with a variety of pharmacological topics, 
including the role of various neurotransmitter systems as well as 
the effects of abused drugs like opiates, cannabinoids, and cocaine 
(reviewed in Buttarelli et al., 2008 and in Carolei et al., 2008a,b). In 
fact, they published the very first two papers that explicitly explored 
the effect of cocaine in this experimental organism (Palladini et al., 
1996; Margotta et al., 1997). Planarians seemed to have a special 
affinity for experimental neurologists; Drs. Harvey B. Sarnat and 
Martin G. Netsky, then at UCLA, argued for the use of planarians 
in the neurosciences (Sarnat and Netsky, 1985, 2002).
Thanks to the works of these clinical scientists, planarians caught 
the attention of a group at Temple University, led by Dr. Robert 
Raffa. Although a “traditional” pharmacologist, in his undergradu-
ate university years he read about planarians in the context of 
James McConnell’s memory retention work. Later on, Dr. Raffa 
began his research projects on planarians at the suggestion of a 
former colleague, and eventually joined efforts with another Temple 
University pharmacologist, Dr. Scott Rawls. In 2000, the Temple 
group published their first planarian pharmacology paper, which 
was on the antipsychotic sulpiride and its antagonistic properties 
against the neurotransmitter dopamine. As Drs. Carolei and Pal-
ladini before them, Raffa’s research was inspired on the similarities 
between the planarian and mammalian dopaminergic systems 
(Raffa et al., 2000). In 2001, the Raffa group published their first 
cocaine/planaria paper (Raffa and Valdez, 2001), which was about 
a series of behaviors reminiscent of “withdrawal symptoms” upon 
exposure to cocaine to planarians. Just as the Rome team did, the 
Temple University team began to explore (and continue exploring 
at the time of this writing) the pharmacology of planarians. The 
planarian pharmacology emphasis of the Temple team was (and 
still is) abused drugs and their generation of specific planarian 
behaviors that are similar to drug-related addiction behaviors in 
vertebrates. Their chosen planarian species is Girardia doroto-
cephala. From the year 2000 to date, this group has published 
close to 50 peer-reviewed papers or book chapters on planarian 
behavioral pharmacology. Some of the specific drug-related top-
ics that the Temple group study in their planaria-related research 
include cross-sensitization (Rawls et al., 2010), anxiogenic-like 
responses (Nayak et al., 2016), dose-related physical dependence 
(Raffa et al., 2007), the dependence of drug exposure duration 
related to the withdrawal response (Sacavage et al., 2008), and 
abstinence-induced withdrawal among other related effects (Raffa 
et al., 2008). Some drugs of abuse that were tested in their work 
included cocaine, nicotine, amphetamines, opioids, cannabinoids, 
and cathinones among others. Their work has been partially re-
viewed in Raffa and Rawls (2008).
Again, just like the Rome group did, the Temple group gathered 
significant evidence indicating that planarians represents an inter-
esting animal model, but more importantly, they further established 
planarians as a model that displays close parallels with vertebrate 
pharmacology. Both groups undoubtedly validated the usefulness 
of these invertebrates in pharmacological research in general and 
on the pharmacology of abused drugs in particular.
Planarians and the search for cocaine antagonists
One of the immediate research directions related to the phar-
macology of drug abuse is the identification of compounds capable 
of alleviating the behavioral or toxic properties of drugs. A premier 
example of this approach was the development of naloxone as an 
antidote against opioid overdose (Strang et al., 2016). An abused 
drug that has resisted this approach is cocaine, which is an excellent 
local anesthetic that is nonetheless a highly addictive substance 
that has proved to be the direct cause of many overdose-related 
fatalities (Loper, 1989; for a brief overview of the history and phar-
macology of cocaine please see Pagán, 2014, chapter 5). So far, 
the identification of a substance useful to clinically treat cocaine 
intoxication has proven elusive (reviewed in Connors and Hoffman, 
2013). There are several interesting links between planarians and 
cocaine. Based on the most current available information online, 
the two earliest publications describing planarian-like organisms 
exposed to cocaine were an anonymous note in the journal The 
American Naturalist (1891) and the second one was a report by 
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Dr. Harold Heath, on the identification of a planarian species from 
Hawaii, published in the Proceedings of the Academy of Natural 
Sciences of Philadelphia (Heath, 1907). In both these works, the 
main objective of using cocaine was to narcotize the worms so 
they could be better examined.
It is important to point out that in the 1891 paper, the observed 
organism, although called a planarian, was actually another type 
of flatworm, an acoel, which is no longer recognized as a planarian 
in phylogenetic terms (Ruiz-Trillo et al., 1999). Also, Dr. Heath’s 
paper dealt with a marine flatworm, albeit a polyclad, which differs 
from the “traditional” triclad planarians that we are discussing here 
(Alvarez-Presas et al., 2008). Therefore, in strict terms, to the best 
of my knowledge, the very first publications on planarians and 
cocaine came from the Rome group, as discussed in the previous 
section (Palladini et al., 1996; Margotta et al., 1997), followed by 
the aforementioned publications of the Temple group. This means 
that in strict terms, planarian/cocaine research is a mere 20 years 
old at the time of this writing. I am honored by the fact that my own 
laboratory has also provided information on the cocaine/planar-
ian connection. I feel fortunate of having had the opportunity to 
contribute to this scientific story and to continue doing so. What 
follows is a brief account of the efforts of my research group at 
West Chester University on the identification of behavioral cocaine 
antagonists using the planarian model.
Parthenolide (Fig. 5) and related molecules are naturally-
occurring chemicals belonging to a class of compounds called 
sesquiterpene lactones, which display a wide range of biological 
effects; these compounds are commonly found in several species 
of plants of the Asteracea family, parthenolide in particular is mainly 
isolated from the feverfew plant (reviewed in Ivanescu et al., 2015 
and in Pagán, 2005, chapter 5).
Preliminary data from my PhD dissertation (Pagán, 2005, 
chapter 5) indicated that parthenolide showed antagonistic activity 
against cocaine on both the nicotinic acetylcholine receptor and 
the dopamine transporter using cell-based assays (reviewed in 
Pagán, 2014, chapter 10). Based on these data, once I became 
an independent investigator, I decided to study whether partheno-
lide or related compounds display anti-cocaine activity in vivo, as 
opposed to the ex vivo (cell-based assays) approach previously 
mentioned. Due to the multiple advantages that the planarian 
model offers, and inspired by planarians papers dealing with their 
neurobiology and pharmacology (Raffa and Valdez, 2001; Raffa 
and Desai, 2005; Sarnat and Netsky, 1985, 2002), I chose these 
worms as my experimental organism. 
Our research demonstrated that parthenolide and related com-
pounds indeed act as cocaine behavioral antagonists on the planar-
ian model. Parthenolide antagonizes cocaine under conditions of 
both acute administration (Pagán et al., 2008) as well as chronic 
administration, effectively preventing the expression of withdrawal-
like behaviors (Rowlands and Pagán, 2008). We also explored the 
structural features of parthenolide-like molecules that endowed them 
with the ability to act as cocaine antagonists in planarians (Baker 
et al., 2011), and provided evidence indicating that parthenolide 
is a specific cocaine antagonist in this model (Pagán et al., 2012). 
Also, using behavioral techniques developed in our laboratory, we 
obtained information about the relative localization of the putative 
binding sites of cocaine and nicotine in the planarian nervous 
system (Pagán et al., 2013). Moreover, our collaborators at the 
University of Puerto Rico, led by Dr. Carlos Jiménez-Rivera, found 
that parthenolide blocks the effect of cocaine on the spontaneous 
firing activity of dopaminergic nerve cells in the ventral tegmental 
area of rats (Schwartz et al., 2010), therefore validating the Rome 
group’s original insight; planarian pharmacology does indeed 
seem to translate to vertebrate pharmacology, particularly that of 
mammals (Buttarelli et al., 2008). To the best of my knowledge, 
there are no other research groups using planarians to search for 
antagonists of drugs of abuse, and much more work needs to be 
done in this exciting area of research. This story is far from over. 
In the next section, we’ll explore some trends about the scientific 
publications on planarians and the pharmacological sciences.
A survey of published papers dealing with planarians 
and pharmacology: 1900-2016
I began this review with the Krogh’s Principle as applied to model 
organisms. Interestingly, the very same paper where he published 
his insights on animal models (Krogh, 1929), included a thorough 
analysis of the published papers on experimental physiology over 
time, an approach similar to the one that I applied in this section, 
with one major difference: Krogh did not have the advantage of 
electronic databases to help him. I simply need to express my 
admiration for his hard labor. On this note, for this section I used 
the NIH’s PubMed database (http://www.ncbi.nlm.nih.gov/pubmed). 
The searches included up to December 2016. Obviously, the results 
reported here will be slightly different than the searches performed 
at the time of publication of this review, as more papers are being 
added to the PubMed database. However, this data will give us 
a good idea on the publication trends related to planarians and 
pharmacology. Also, please note that by necessity I chose the 
search keywords arbitrarily. For example, to search articles about 
planarians, I used the following array: 
SEARCH 1 = (girardia OR dugesia OR schmidtea OR polycelis 
OR phagocata OR planaria OR planarian OR planarians)
Which represent the five planarian genera that are most com-
monly used as research subjects as well as the variations on the 
“planarian” term. I did not include terms like “flatworm” in these 
search keywords because the results would then have included 
papers about non-planarian organisms, like parasitic worms and 
acoels, for example, which although quite interesting in their own 
right, are beyond the scope of this review.
To search for the papers about pharmacology and planarians 
I used the following array:
SEARCH 2 = (girardia OR dugesia OR schmidtea OR polycelis 
OR planaria OR phagocata OR planarian OR planarians) AND 
(pharmacology OR drug OR drugs OR pharmacological)
Fig. 5. The chemical structure of 
Parthenolide.
524    O.R. Pagán
The overall results for both SEARCH 1 and SEARCH 2 are 
shown in Fig. 6. The data shows that of the planarian-related 
papers published between 1900 and 2016, approximately 24 % 
were of a pharmacological nature.
Next, I refined the results by using the PubMed feature that allows 
for the custom selection of publication dates, as shown in Fig. 7.
The data in Fig. 7 indicates that there is a clear trend show-
ing an increase on the number of planarian papers per year. The 
same applies to planarian pharmacology papers, albeit to a lesser 
extent, as expected due to the search constraints. Interestingly, 
the data show a decrease on the number of planarian papers per 
year between 1971 and 1990, which roughly correlates with the 
decrease in popularity of the planarian model as a consequence 
of the aforementioned controversial research of James McConnell. 
Curiously, when the data are plotted as the fraction of planarian 
papers dealing with pharmacology (Fig. 7, inset), it shows that about 
40 % of the planarian papers published between 1971 and 1990 
were related to pharmacology. It seems that even though planar-
ians lost some popularity among the general scientific population, 
it gained a relatively higher interest from pharmacologically-minded 
scientists, arguably inspired by Dr. Carolei’s 1975 paper (Carolei et 
al., 1975). For the last 25 five years or so, the percent of planarian 
papers related to pharmacology has stabilized to about 24 % of the 
total planarian-related papers (Fig. 7, inset), in close agreement 
with the data shown in Fig. 6. 
Please note that this database strategy used in this work is 
limited by the fact that by necessity one needs to work with the 
keywords explicitly stated anywhere within the text. This means 
that there will be papers that albeit of a pharmacological nature, 
may escape this search strategy because pharmacology-related 
terms may not be explicitly stated in the text. Case in point: the 
two earliest papers that came up in the planarian search (Moore, 
1918; Stringer, 1917) dealt with the behavioral effects of strychnine 
on planarians and starfish, and the effect of lithium chloride and 
magnesium chloride on planarian locomotion respectively. Both 
papers are undoubtedly pharmacological in nature, yet they were not 
“caught” by the search. The main implication of this limitation is that 
we are seeing an underestimation of the pharmacological-themed 
planarian papers. To minimize this limitation, when searching for 
planarian papers on drugs of abuse, I used SEARCH 1 combined 
with the appropriate keywords (i.e., cocaine, cannabinoid, etc.) 
as shown in Fig. 8.
Fig. 8 shows an increasing trend in the publication of planarian-
related papers with a pharmacological theme, specifically about 
drugs of abuse. The inset shows the number of planarian papers 
that include keywords related to specific abused drugs 1900-2016, 
as indicated. It is fully expected that this trend will continue.
The future: developmental and regeneration 
pharmacology: Planarians lead the way.
Regular readers of this journal are quite familiar with the formal 
distinctions between the processes of development and regenera-
tion. Therefore, I will not revisit their respective definitions here 
except to say that these are two closely related areas, with important 
similarities and differences in terms of their specific mechanisms 
and physiological aspects. Nonetheless, in many instances they 
are treated as one and the same phenomenon, even in scientific 
publications, which oftentimes leads to controversy, a controversy 
that is beyond the scope of our discussion. For a review of the 
similarities and differences between the phenomena of develop-
ment and regeneration please refer to Vervoort (2011).
Efforts regarding the advance of developmental pharmacology 
are mainly focused on the neonatal and pediatrics application of 
such principles (Kearns et al., 2003; Samardzic et al., 2015). The 
overwhelming majority of the literature in this area deals primarily 
with aspects of dosage, as well as the ADME pharmacological 
principle (Administration, Distribution, Metabolism, and Elimination) 
and their effect on the normal development of young patients. These 
young patients were widely referred to as “therapeutic orphans” 
because of the relative lack of data regarding the effects of age 
on pharmacological treatments (Berde and Cairns, 2000). I was 
unable to obtain any publications on the correction of fully under-
stood developmental defects through pharmacological approaches. 
Probably the only example of this practice in preventive medicine 
Fig. 6. Published papers on planarians (SEARCH 1, see text), and on 
planarians and pharmacology (SEARCH 2, see text). The numbers on 
top of the bars represent the number of papers. 
Fig. 7. Planarian (SEARCH 1) and planarian/pharmacology papers 
(SEARCH 2) 1900-2016. Inset: Fraction of planarian papers that dealt with 
pharmacological aspects (see text). 
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is the supplementation of folic acid to pregnant women, shown to 
decrease the risk of neural tube defects, a congenital defect that 
prevents the proper closure of the neural tube. However, even in 
this case, the genetic and biochemical mechanisms of such protec-
tive effect are largely unknown (Imbard et al., 2013). 
As in the case of developmental pharmacology, most of the 
scientific literature on regeneration pharmacology is oriented 
towards applications to the clinical sciences, specifically with the 
repair of various organ systems. In fact, a formal definition of the 
field of regenerative medicine in general is the “… repair and/or 
replacement of damaged cells, tissues, and organs for functional 
restoration” (Christ et al., 2013). Regeneration pharmacology aims 
to the integration of several “traditional” aspects of regenerative 
medicine, namely molecular biology, biomaterials and tissue en-
gineering, nanotechnology, and physiology among others, with a 
pharmacological approach (Andersson and Christ, 2007; Christ 
et al., 2013).
In this final section of this review, I argue in favor of planaria as 
the proverbial “flagship” animal model in developmental pharma-
cology and regeneration pharmacology. This class of organisms 
possesses a unique set of characteristics that makes it particularly 
endowed to serve as a link to connect the research efforts of sci-
entists of different disciplines. 
Planarians have long been proposed as useful animal models 
for regenerative medicine (Gentile et al., 2011; Karami et al., 2015; 
Matthews and Levin, 2016; Umesono et al., 2011). Also, traditionally, 
planarian worms have been used as an animal model in develop-
mental biology, mainly because many planarian species possess 
the extraordinary ability of completely regenerating lost body parts 
(Reddien and Sánchez Alvarado, 2004; Sánchez Alvarado, 2006; 
Newmark et al., 2003; Sánchez Alvarado, 2004a,b). In strict terms, 
most organisms are capable of some degree of regeneration, and 
in general, the closer they are to the vertebrate line, the lesser the 
regenerative abilities they may display. There are other organisms 
which are as remarkable, if not more, as planarians are in terms 
of regenerative properties. Well-known examples are certain 
sponge species and the small freshwater cnidarian hydra. These 
two types of organisms tolerate complete cell dissociation and in 
the absence of any chemical insults, are able of reforming their 
entire body structure (Alexander et al., 2015; Holstein et al., 2003). 
This is an extreme capability not shared by planarians. It is without 
dispute that sponges and cnidarians are invaluable regeneration 
models. What sets planarians apart in terms of regeneration and 
development is that they are relatively complex organisms in terms 
of organ structure (Roberts-Galbraith et al., 2015). Moreover, 
the regenerative prowess of some planarian species include the 
complete regeneration of the brain and nervous system (Agata 
and Umesono, 2008; Cebrià, 2007; Cebrià and Newmark, 2002; 
Cebrià et al., 2002; Fraguas et al., 2012; Umesono and Agata, 
2009; Umesono et al., 2011). These facts, alongside the aforemen-
tioned relatively complex behaviors that these organisms express 
naturally and in response to exposure of a variety of drugs, make 
planarians unique organisms to integrate the fields of regeneration, 
developmental biology, and pharmacology. 
Another advantage of the use of the planarian model in this con-
text is that they are very well characterized in genomic terms. Since 
2007, the Schmidtea mediterranea Genome Database (SmedDB; 
http://smedgd.stowers.org), now in its second generation (Robb et 
al., 2015) has provided a much needed resource where genomic 
and transcriptomic studies from this organism are compiled (For 
examples please see Abril et al., 2010, Nishimura et al., 2012, 
and Resch et al., 2012). Transcriptomic analyses have also been 
performed in Dugesia japonica (Chan et al., 2016; Nishimura et 
al., 2012, 2015; Pang et al., 2016; Qin et al., 2016).
As useful as molecular approaches are, allow me to offer a 
note of caution on the use of inbred and clonal strains from a 
pharmacological perspective. Natural populations of any organ-
ism will generally display some degree of genetic variability. This 
is an integral aspect of the evolutionary process. This means 
that in such natural populations we would expect to see a corre-
spondent degree of variability in the pharmacological responses 
induced by any tested drug or toxin. The human pharmacogenetic 
variability observed by the expression of multiple phenotypes in 
response to a single drug also applies to our fellow organisms on 
this planet. The study of the pharmacologically diverse effects on 
non-homogeneous populations will paint a more realistic picture 
of the incidence of any pharmacologically-related phenotypes than 
studies on clonal lines. Natural populations are exposed to various 
types of environmental stimuli that contribute to selective pressure, 
an established occurrence that is widely considered a driving force 
on evolution, whether it comes from biotic or abiotic factors. One 
of the consequences of such pressure is genetic heterogeneity 
in a population. In these lines, the planarians currently used to 
model the genetic data (S. mediterranea and Dugesia japonica) 
are usually more genetically uniform than natural populations. It is 
important to reiterate that there is no doubt that studies on clonal 
lines provide essential information about fundamental biological 
processes. Nonetheless, I submit that any pharmacological con-
clusion based exclusively on such planarian clonal lines must be 
examined in light of data obtained from more natural populations 
in order to refine and complement the information obtained through 
populations of genetically similar organisms. Several species of 
planarians of the Girardia, Dugesia, and Phagocata genera are 
currently commercially available through several suppliers and are 
Fig. 8. Planarian (SEARCH 1) combined with various search terms 
associated with drugs of abuse as indicated in the inset. (SEARCH 
2) 1900-2016. Inset: The same data separated into the individual drugs of 
abuse, as indicated. 
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therefore available for such pharmacological studies.
Another important bioinformatics approach designed to store and 
disseminate planarian regeneration-related research is the develop-
ment of the Planform database (PlanformDB; http://lobolab.umbc.
edu/planform/; Lobo et al., 2013). This database collects more than 
a thousand separate published experiments and just as SmedGD, 
PlanformDB is under constant expansion. In contrast to SmedGD, 
PlanformDB includes information from a wider range of planar-
ian species. There is little doubt that SmedGD and PlanformDB 
complement each other and their interaction will surely facilitate the 
exchange of information between scientists across different disci-
plines, significantly advancing the progress of planarian research.
A recent series of quite interesting experiments perfectly show-
case the integration of the disciplines of development, regeneration, 
and pharmacology. The research that I will briefly describe comes 
from the laboratory of Dr. Michael Levin of Tufts University. The basis 
of their work is the recognition that bioelectrical properties play a 
central role in regeneration phenomena (Durant et al., 2016; Levin 
2012, 2014). Specifically, they have explored the pharmacological 
manipulation of gap junctions, which are channels between cells 
formed by specific proteins (connexins) that modulate the con-
nections between cells. Connexins selectively allow the exchange 
of their internal components, which frequently include ions. Thus, 
these proteins modulate the bioelectrical properties between cells. 
These proteins are being recognized as modulators of the planarian 
stem cell response as related to tissue maintenance, repair, and 
remodeling (Peiris and Oviedo, 2013).
By pharmacologically treating planarians with n-octanol, a 
connexin blocker, they were able to modulate the physiology of 
planarian stem cells from Dugesia japonica to induce the formation 
of multiple heads and their associated neural structures (Oviedo 
et al., 2010). In a related note, ectopic brain tissue formation in 
planarians was also observed a few years ago by modulating the 
function of fibroblast growth factor receptors (Cebrià et al., 2002). 
The recent work by the Levin laboratory describes a series of experi-
ments (Emmons-Bell et al., 2015) in which they treated decapitated 
planarians of a commercially available planarian species (Girardia 
dorotocephala) with 123 mM n-octanol for three days. After this pe-
riod, the n-octanol was washed away and the worms were allowed 
to regenerate for seven additional days. Many worms regenerated 
normally (about 35 % of the total), but a significant fraction of them 
differed drastically on their head morphology; these worms’ head 
shapes were closely similar to the head shapes of different planar-
ian species, which they referred to as “pseudo-X”, X being Girardia 
dorotocephala, Dugesia japonica, Polycelis felina, and Schimidtea 
mediterranea (Fig. 9). In addition to the appearance of various head 
shapes in the regenerating planarians, three additional aspects of 
this series of experiments are quite significant: (1) The proportion 
of the head shapes developed of the total planarians tested (i.e., 
the relative percentages of pseudo-Girardia, pseudo-Dugesia, 
pseudo-Polycelis, and pseudo-Schmidtea), (2) Their associated 
brain structures and distribution of neoblasts (planarian stem cells), 
and (3) The eventual return to the original Girardia-like head shape, 
as if the original genome of the planarian was “reasserting” itself. In 
brief, the number of planarians regenerating specific head shapes 
roughly correlated with the phylogenetic distance from the parent 
species (G. dorotocephala). Most of the worms regenerated the 
parent form (~35 %), followed by pseudo-D. japonica (~30 %), 
pseudo-S. mediterranea (~15 %), and pseudo-P. felina (~5 %; Fig. 
9). Fifteen percent of the worms failed to regenerate. Interestingly, 
the morphological differences were not limited to their head shape; 
their brain connectivity and overall morphology were changed as 
well, resembling that of the “pseudo” species. Finally, the change in 
head morphology was transient. When the worms were allowed to 
regenerate beyond day 10, they reverted to a shape similar to the 
parental form, again, roughly in phylogenetic distance order, as if 
their “native” genome was reactivated. This differed from previous 
experiments where the formation of additional heads in D. japonica 
was a permanent phenomenon (Oviedo et al., 2010). The Levin 
group further proposed the beginnings of a model that describes 
how bioelectrical properties can be manipulated to generate distinct 
morphologies.
From the perspective of the main topic of this review, the results 
described in Emmons-Bell et al.,2015) seems to represent the first 
demonstration where pharmacology, regeneration, and development 
were explicitly related in an experimental framework. In essence, 
the pharmacological manipulation of connexins disrupted the normal 
regeneration of G. dorotocephala to G. dorotocephala, inducing the 
development of the pseudo-D. japonica, pseudo-S. mediterranea, 
and pseudo-P. felina heads as well as their corresponding brain 
morphologies, which subsequently “re-developed” into their original 
phenotype. If and when developmental biology, regeneration biology, 
and pharmacology become truly integrated into a bona fide area 
of research, Emmons-Bell et al.,2015) should be recognized as a 
landmark study of this emerging interdisciplinary field.
Conclusions and Perspectives
The fields of planarian pharmacology and neuroscience are 
undergoing an interesting period of expansion. This includes the 
exciting interdisciplinary areas of developmental and regeneration 
pharmacology. I strongly believe that the interdisciplinary nature of 
this novel approach using planarians must begin with a perspec-
tive shift on behalf of the relevant scientists. In other words, a 
pharmacologist should be as conversant and comfortable talking 
Fig. 9. Excerpt of the main results of Emmons-Bell et al., (2015) on 
the transient pharmacological modification of the apparent phenotype of 
regenerating Girardia dorotocephala (see text). Illustration courtesy of Mr. 
Alexis G. Pagán.
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about imaginal discs and stem cells as when talking about recep-
tor theory. The same reasoning applies to the developmental and 
regeneration biologist. I speak from experience. When I submitted 
our group’s first paper linking regeneration and pharmacology 
(Pagán et al., 2013), the specific areas of expertise of the paper’s 
reviewers (i.e., pharmacology vs. developmental biology) were im-
mediately apparent. In a way, when responding to the reviewers I 
felt like a diplomat coordinating a summit between two superpowers 
that spoke different native languages. To have a first row seat while 
to scientific disciplines begin to formally collaborate is a singular 
honor for a scientist. Some of the immediately apparent benefits 
from the synergy of regeneration, development, and pharmacol-
ogy research will surely include the clarification of the fundamental 
processes that control how an organism develops and regenerates. 
Moreover, this research could point the way to the discovery of 
small molecules that affect these processes, potentially allowing 
their pharmacological manipulation with obvious implications for 
the medical sciences. Conversely, a more complete understanding 
of regeneration and development could shed light important phar-
macological mechanisms, as it is a well-established fact that the 
specific effect of many drugs is dependent on the developmental 
stage of the subject. I believe that this is just the beginning of a 
significant wave of advances in the biomedical sciences. Planar-
ians are exceptionally positioned to help us achieve this goal, and 
therefore they should lead the way.
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